ID

31045

Descripción

Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00674258

Link

https://clinicaltrials.gov/show/NCT00674258

Palabras clave

Versiones (1)
  1. 13/7/18 13/7/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

13 de julio de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Non Small Cell Lung Cancer NCT00674258

Inglés

Eligibility Non Small Cell Lung Cancer NCT00674258

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
disease characteristics
Descripción

Disease characteristic

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0599878
advanced or recurrent non small cell lung cancer
Descripción

Non-Small Cell Lung Carcinoma Advanced | Non-small cell lung cancer recurrent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
UMLS CUI [2]
C0278517
second line or later therapeutic status patient characteristics
Descripción

Second line treatment | Line of Therapy Ordinal number | Client Characteristics

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1710038
UMLS CUI [2,1]
C4524693
UMLS CUI [2,2]
C0439080
UMLS CUI [3]
C0815172
ecog performance status 0-2
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy > 3 months
Descripción

Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
hla-a*2402
Descripción

HLA-A*2402

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1098634
laboratory values as follows
Descripción

Laboratory Results

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1254595
2000/mm3<wbc<15000/mm3
Descripción

White Blood Cell Count procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023508
platelet count>100000/mm3
Descripción

Platelet Count measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032181
bilirubin < 3.0mg/dl
Descripción

Serum total bilirubin measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1278039
asparate transaminase < 150iu/l
Descripción

Aspartate aminotransferase measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201899
alanine transaminase < 150iu/l
Descripción

Alanine aminotransferase measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201836
creatinine < 3.0mg/dl
Descripción

Creatinine measurement, serum

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
able and willing to give valid written informed consent
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnancy(woman of childbearing potential:refusal or inability to use effective means of contraception)
Descripción

Pregnancy | Childbearing Potential Contraceptive methods Refused | Childbearing Potential Contraceptive methods Unable

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
UMLS CUI [2,3]
C1705116
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0700589
UMLS CUI [3,3]
C1299582
breastfeeding
Descripción

Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006147
active or uncontrolled infection
Descripción

Communicable Disease | Communicable Disease Uncontrolled

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2,1]
C0009450
UMLS CUI [2,2]
C0205318
concurrent treatment with steroids or immunosuppressing agent
Descripción

Steroid therapy | Immunosuppressive Agents

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0149783
UMLS CUI [2]
C0021081
prior chemotherapy,radiation therapy, or immunotherapy within 4 weeks
Descripción

Prior Chemotherapy | Prior radiation therapy | Prior Immunotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1514457
UMLS CUI [2]
C0279134
UMLS CUI [3]
C1514461
uncontrolled brain and/or intraspinal metastasis
Descripción

Metastatic malignant neoplasm to brain Uncontrolled | Secondary malignant neoplasm of vertebral column Uncontrolled

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0684550
UMLS CUI [2,2]
C0205318
decision of unsuitableness by principal investigator or physician-in-charge
Descripción

Study Subject Participation Status Inappropriate

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C1548788
Volver a la parte superior de la página

Similar models

Eligibility Non Small Cell Lung Cancer NCT00674258

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Disease characteristic
Item
disease characteristics
boolean
C0599878 (UMLS CUI [1])
Non-Small Cell Lung Carcinoma Advanced | Non-small cell lung cancer recurrent
Item
advanced or recurrent non small cell lung cancer
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0278517 (UMLS CUI [2])
Second line treatment | Line of Therapy Ordinal number | Client Characteristics
Item
second line or later therapeutic status patient characteristics
boolean
C1710038 (UMLS CUI [1])
C4524693 (UMLS CUI [2,1])
C0439080 (UMLS CUI [2,2])
C0815172 (UMLS CUI [3])
ECOG performance status
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy > 3 months
boolean
C0023671 (UMLS CUI [1])
HLA-A*2402
Item
hla-a*2402
boolean
C1098634 (UMLS CUI [1])
Laboratory Results
Item
laboratory values as follows
boolean
C1254595 (UMLS CUI [1])
White Blood Cell Count procedure
Item
2000/mm3<wbc<15000/mm3
boolean
C0023508 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count>100000/mm3
boolean
C0032181 (UMLS CUI [1])
Serum total bilirubin measurement
Item
bilirubin < 3.0mg/dl
boolean
C1278039 (UMLS CUI [1])
Aspartate aminotransferase measurement
Item
asparate transaminase < 150iu/l
boolean
C0201899 (UMLS CUI [1])
Alanine aminotransferase measurement
Item
alanine transaminase < 150iu/l
boolean
C0201836 (UMLS CUI [1])
Creatinine measurement, serum
Item
creatinine < 3.0mg/dl
boolean
C0201976 (UMLS CUI [1])
Informed Consent
Item
able and willing to give valid written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Childbearing Potential Contraceptive methods Refused | Childbearing Potential Contraceptive methods Unable
Item
pregnancy(woman of childbearing potential:refusal or inability to use effective means of contraception)
boolean
C0032961 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C1705116 (UMLS CUI [2,3])
C3831118 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C1299582 (UMLS CUI [3,3])
Breast Feeding
Item
breastfeeding
boolean
C0006147 (UMLS CUI [1])
Communicable Disease | Communicable Disease Uncontrolled
Item
active or uncontrolled infection
boolean
C0009450 (UMLS CUI [1])
C0009450 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Steroid therapy | Immunosuppressive Agents
Item
concurrent treatment with steroids or immunosuppressing agent
boolean
C0149783 (UMLS CUI [1])
C0021081 (UMLS CUI [2])
Prior Chemotherapy | Prior radiation therapy | Prior Immunotherapy
Item
prior chemotherapy,radiation therapy, or immunotherapy within 4 weeks
boolean
C1514457 (UMLS CUI [1])
C0279134 (UMLS CUI [2])
C1514461 (UMLS CUI [3])
Metastatic malignant neoplasm to brain Uncontrolled | Secondary malignant neoplasm of vertebral column Uncontrolled
Item
uncontrolled brain and/or intraspinal metastasis
boolean
C0220650 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0684550 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Study Subject Participation Status Inappropriate
Item
decision of unsuitableness by principal investigator or physician-in-charge
boolean
C2348568 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial